BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32148084)

  • 21. Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study.
    Ramagopalan SV; Stamp E; Sammon CJ; Besford M; Carroll R; Mehmud F; Alikhan R
    Future Cardiol; 2019 Jul; 15(4):301-309. PubMed ID: 31140872
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic renal disease is not chronic kidney disease: implications for use of the QRISK and Joint British Societies risk scores.
    Stevens SL; Stevens RJ; Hobbs FD; Lasserson DS
    Fam Pract; 2016 Feb; 33(1):57-60. PubMed ID: 26585911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up.
    Naruse Y; Tada H; Sekiguchi Y; Machino T; Ozawa M; Yamasaki H; Igarashi M; Kuroki K; Itoh Y; Murakoshi N; Yamaguchi I; Aonuma K
    Heart Rhythm; 2011 Mar; 8(3):335-41. PubMed ID: 21056121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are Existing Risk Scores for Nonvalvular Atrial Fibrillation Useful for Prediction or Risk Adjustment in Patients With Chronic Kidney Disease?
    McAlister FA; Wiebe N; Jun M; Sandhu R; James MT; McMurtry MS; Hemmelgarn BR; Tonelli M
    Can J Cardiol; 2017 Feb; 33(2):243-252. PubMed ID: 27956042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can billing codes accurately identify rapidly progressing stage 3 and stage 4 chronic kidney disease patients: a diagnostic test study.
    Jalal K; Anand EJ; Venuto R; Eberle J; Arora P
    BMC Nephrol; 2019 Jul; 20(1):260. PubMed ID: 31299918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD).
    Kingswood JC; Nasuti P; Patel K; Myland M; Siva V; Gray E
    J Med Econ; 2016 Dec; 19(12):1116-1126. PubMed ID: 27310569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Outcomes of Left-Sided Valvular Heart Disease Associated With Chronic Kidney Disease.
    Samad Z; Sivak JA; Phelan M; Schulte PJ; Patel U; Velazquez EJ
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29021274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of atrial fibrillation in CKD and non-CKD populations: A cross-sectional analysis from the Kailuan study.
    Guo Y; Gao J; Ye P; Xing A; Wu Y; Wu S; Luo Y
    Int J Cardiol; 2019 Feb; 277():125-129. PubMed ID: 30473335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink.
    Iwagami M; Tomlinson LA; Mansfield KE; McDonald HI; Smeeth L; Nitsch D
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):792-801. PubMed ID: 28397412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial Fibrillation and Risk of ESRD in Adults with CKD.
    Bansal N; Xie D; Tao K; Chen J; Deo R; Horwitz E; Hsu CY; Kallem RK; Keane MG; Lora CM; Raj D; Soliman EZ; Strauss L; Wolf M; Go AS;
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1189-1196. PubMed ID: 27073197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease.
    Arnson Y; Hoshen M; Berliner-Sendrey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    Cardiology; 2020; 145(3):178-186. PubMed ID: 31955174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
    Coleman CI; Kreutz R; Sood NA; Bunz TJ; Eriksson D; Meinecke AK; Baker WL
    Am J Med; 2019 Sep; 132(9):1078-1083. PubMed ID: 31054829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of glomerular filtration rate equations for chronic kidney disease patients at the G3a stage: a single-center cross-sectional study.
    Dou Y; Sun X; Liu D; Zhang L; Xiao J; Cheng G; Yu D; Zhao Z
    BMC Res Notes; 2017 Feb; 10(1):107. PubMed ID: 28235417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of unlabeled chronic kidney disease among inpatients at a tertiary-care hospital.
    Ferris M; Shoham DA; Pierre-Louis M; Mandhelker L; Detwiler RK; Kshirsagar AV
    Am J Med Sci; 2009 Feb; 337(2):93-7. PubMed ID: 19214023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interatrial block, P terminal force or fragmented QRS do not predict new-onset atrial fibrillation in patients with severe chronic kidney disease.
    Hellman T; Hakamäki M; Lankinen R; Koivuviita N; Pärkkä J; Kallio P; Kiviniemi T; Airaksinen KEJ; Järvisalo MJ; Metsärinne K
    BMC Cardiovasc Disord; 2020 Oct; 20(1):437. PubMed ID: 33028216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated glomerular filtration rate within the normal or mildly impaired range and incident non-valvular atrial fibrillation: Results from a population-based cohort study.
    Eisen A; Haim M; Hoshen M; Balicer RD; Reges O; Leibowitz M; Iakobishvili Z; Hasdai D
    Eur J Prev Cardiol; 2017 Jan; 24(2):213-222. PubMed ID: 27798368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe.
    Cainzos-Achirica M; Varas-Lorenzo C; Pottegård A; Asmar J; Plana E; Rasmussen L; Bizouard G; Forns J; Hellfritzsch M; Zint K; Perez-Gutthann S; Pladevall-Vila M
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):713-723. PubMed ID: 29570897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and management of chronic kidney disease in primary care patients in the UK.
    Jameson K; Jick S; Hagberg KW; Ambegaonkar B; Giles A; O'Donoghue D
    Int J Clin Pract; 2014 Sep; 68(9):1110-21. PubMed ID: 24852335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of peripheral arterial disease diagnosed by ankle brachial index among chronic kidney disease patients in a tertiary care unit.
    Laghari S; Ullah K; Masroor I; Butt G; Kifayat F
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):924-30. PubMed ID: 26354563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.